|4Feb 13, 1:08 PM ET

Caveney Brian J 4

Research Summary

AI-generated summary

Updated

Labcorp (LH) EVP Brian Caveney Receives 740 RSUs; 211 Shares Withheld

What Happened

  • Brian J. Caveney, EVP (Pres of ED, CMO & CSO) of Labcorp Holdings (LH), had 740 restricted stock units (RSUs) convert to common shares on February 11, 2026. The filing shows 211 of those shares were withheld to satisfy tax withholding obligations (reported value $289.89 per share; $61,167 withheld), leaving approximately 529 net shares issued to him. The gross value of the 740 shares at $289.89 is about $214,519; the net shares retained are worth roughly $153,352 at that price.

Key Details

  • Transaction dates: conversion/vesting on 2026-02-11; Form 4 filed 2026-02-13 (timely).
  • Reported entries: M = exercise/conversion of derivative (740 shares issued); F = tax withholding (211 shares withheld at $289.89, $61,167).
  • Net shares retained after withholding: ~529 shares (740 issued − 211 withheld).
  • Footnotes: F1–F4 indicate these were RSUs (1 RSU = 1 share), tax withholding via share surrender, vesting is part of a grant that vests in three equal annual installments beginning Feb 11, 2026, and the filing notes aggregate RSUs held by the reporting person.
  • No late filing flag in the provided data.

Context

  • This was not an open-market purchase or a sale for investment purposes but a routine conversion/vesting of RSUs with shares withheld to cover taxes (a standard cashless settlement). Such vesting events are compensation-related and do not necessarily signal a change in the insider’s view of the company.